Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-175438
Filing Date
2025-08-07
Accepted
2025-08-07 16:15:37
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-3 d926581ds3.htm S-3 329776
2 EX-4.5 d926581dex45.htm EX-4.5 364471
3 EX-4.6 d926581dex46.htm EX-4.6 396321
4 EX-5.1 d926581dex51.htm EX-5.1 30252
5 EX-23.1 d926581dex231.htm EX-23.1 1907
6 EX-FILING FEES d926581dexfilingfees.htm   iXBRL EX-FILING FEES 28904
7 GRAPHIC g926581123snap1.jpg GRAPHIC 4750
8 GRAPHIC g926581st15.jpg GRAPHIC 2767
  Complete submission text file 0001193125-25-175438.txt   1305231

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT d926581dexfilingfees_htm.xml XML 10848
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289359 | Film No.: 251194230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)